| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |